FDA hears input on psychedelics, PDUFA, lung cancer’s next-gen therapies boost survival

0:00-22:11

The FDA held a public forum on Monday to discuss the future of psychedelic therapeutics, followed by a meeting on Wednesday regarding recommendations for reauthorizing the Prescription Drug User Fee Act the day after launching its TrialBlazer initiative. Meanwhile, Definium Therapeutics notched another late-stage trial win for its LSD drug, and Novartis continues to reel from the company’s triple asset stumble.

Publisher

BioSpace

Published

September 16, 2026

Duration

22 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

B

BioSpace

@biospace

#fdahearsinput #lungcancers #gentherapiesboost #lifesciences

The Nile